Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms

Archives of Surgery

Volumn 138, Issue 6, 2003, Pages 610-618

  Wiesenauer, Chad A ^a   Schmidt, C Max ^a,b,c   Cummings, Oscar W ^a,b   Yiannoutsos, Constantin T ^a   Howard, Thomas J ^a,b   Wiebke, Eric A ^a,b,c   Goulet Jr , Robert J ^a,b   McHenry, Lee ^a   Sherman, Stuart ^a   Lehman, Glen A ^a   Cramer, Harvey ^a   Madura, James A ^a,b   Moossa, Rahim ^d   Prinz, Richard A ^d   McMasters, Kelly ^d   DeBord, James R ^d   Talamonti, Mark ^d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GLUCOSE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTADENOMA; CYTODIAGNOSIS; DIABETES MELLITUS; DYSPLASIA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GASTROSTOMY; GLUCOSE BLOOD LEVEL; HUMAN; JAUNDICE; MAJOR CLINICAL STUDY; MALE; PANCREAS BIOPSY; PANCREAS CANCER; PANCREAS INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SYMPTOM;

ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0038661392     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.138.6.610     Document Type: Review

References (31)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
2. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998;227:821-831.
3. Kalser MH, Ellenberg SS. Pancreatic cancer, adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899-903.
4. Moskaluk CA, Hruban RH, Schutte M, et al. Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma. Diagn Mol Pathol. 1997;6:85-90.
5. Hruban RH, Petersen GM, Goggins M, et al. Familial pancreatic cancer. Ann Oncol. 1999;10(suppl 4):69-73.
6. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an Investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425:357-367.
7. Sohn TA, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Lillemoe KD. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg. 2001;234:313-322.
8. Ohhashi K, Murakimi Y, Maruyama M, Takekoshi T, Ohta H, Ohhashi I. Four cases of mucous secreting pancreatic cancer [in Japanese]. Prog Dig Endosc. 1982;20:348-351.
9. Itai Y, Ohhashi K, Nagai H, et al. "Ductectatic" mucinous cystadenoma and cystadenocarcinoma of the pancreas. Radiology. 1986;161:697-700.
10. Evans DB, Lee JE, Charnsangavej C. Unusual pancreatic tumors. In: Cameron JL, ed. Current Surgical Therapy. Baltimore, Md: Mosby; 1998.
11. Sugiura H, Kondo S, Islam HK, et al. Clinicopathologic features and outcomes of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology. 2002;49:263-267.
12. Falconi M, Salvia R, Bassi C, Zamboni G, Talamini G, Pederzoli P. Clinicopathological features and treatment of intraductal papillary mucinous tumors of the pancreas. Br J Surg. 2001;88:376-381.
13. Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol. 2000;95:441-445.
14. Sho M, Nakajima Y, Kanehiro H, et al. Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas. World J Surg. 1998;22:874-878.
15. Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS. Intraductal papillarymucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer. 2002;94:62-77.
16. Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer. 2001;92:1807-1817.
17. Zhou XH, Obuchowski NA, McClish DK. Statistical Methods in Diagnostic Medicine. New York, NY: John Wiley & Sons Inc; 2002.
18. Metz CE, Kronman HB. Statistical significance tests for binormal ROC curves. J Math Psychol. 1980;22:218-243.
19. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
20. Loftus EV, Olivares-Pakzad BA, Batts KP, et al. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Gastroenterology. 1996;110:1909-1918.
21. Gigot J, Deprez P, Sempoux C, et al. Surgical management of intraductal papillary mucinous tumors of the pancreas. Arch Surg. 2001;136:1256-1262.
22. Cellier C, Cuillerier E, Palazzo L, et al. Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc. 1998;47:42-49.
23. Paye F, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery. 2000;127:536-544.
24. Uehara H, Nakaizumi A, Iishi H, et al. Cytologic examination of pancreatic juice for differential diagnosis of benign and malignant mucin-producing tumors of the pancreas. Cancer. 1994;74:826-833.
25. Islam HK, Fujioka Y, Tomidokoro T, et al. Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas: diagnostic and biologic significance. Hepatogastroenterology. 1999;46:2599-2605.
26. Raimondo M, Tachibana I, Urrutia R, Burgart LJ, DiMagno EP. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol. 2002;97:2553-2558.
27. Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372-1377.
28. Holme JB, Jacobsen NO, Rokkjaer M, Kruse A. Total pancreatectomy in six patients with intraductal papillary mucinous tumour of the pancreas: the treatment of choice. HPB Surg. 2001;3:257-262.
29. Blanchet MC, Andreelli F, Scoazec JY, et al. Total pancreatectomy for mucinous pancreatic tumor [in French]. Ann Chir. 2002;127:439-448.
30. Traverso LW. Surgical treatment of intraductal papillary mucinous neoplasms of the pancreas: the aggressive approach. J Gastrointest Surg. 2002;6:662-663.
31. Hara T, Yamaguchi T, Ishihara T, et al. Diagnosis and patient management of intraductal papillary mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography. Gastroenterology. 2002;122:34-43.